Working to facilitate rapid translation of scientific discoveries into therapeutics

Laurent Audoly

Laurent AUDOLY_IRPF cutted

Laurent Audoly, PhD

Dr. Laurent Audoly is Global Head of Drug Development and Translational Medicine at Fabre Laboratories overseeing activities from discovery, preclinical characterization to product advancement onto the market. Laurent is also President and General Manager of the Pierre Fabre Orphan Diseases unit. Prior, Laurent has held positions of increasing leadership responsibilities in both the pharmaceutical and biotech industries leading to the identification, development, and drug approvals in inflammation, cardiovascular diseases, and oncology. He studied medicine and chemistry and graduated with a Ph.D. in Pharmacology from Vanderbilt University. Laurent was awarded a fellowship from the American Heart Association during his training at Duke University. Laurent has maintained strong ties with the academic world as an Associate Professor (Adj) at Duke NUS Graduate Medical School. He has also served on NIH study sections, given seminars at universities across the world, and also published > 70 papers. He is also on the board of multiple healthcare organizations aimed at accelerating the discovery and advancement of novel therapies for patients.

2013-2021©European Society for Translational Medicine (EUSTM)